Cancer centers around the country are implementing new measures and modifying treatment protocols to reduce the risk of 2019 coronavirus disease (COVID-19) to healthcare workers and people with cancer. At NYU Langone Health’s Perlmutter Cancer Center, doctors are introducing telemedicine to limit exposure to the virus and using chemotherapy and radiation to delay surgeries until the pandemic has abated, Abraham Chachoua, MD, associate director of cancer services at Perlmutter Cancer Center, tells OncLive.

“We’re not at the point of stopping treatment altogether, and we’re not going to do that, but there’s no reason that someone who is on maintenance chemotherapy who would be stable for a year has to come in every three weeks,” says Dr. Chachoua, who is the Jay and Isabel Fine Professor of Oncology in the Department of Medicine. “We could delay that treatment, so we’ve tried to do that.”

Read more from OncLive (registration required).